emavusertib,ibrutinib
janssen,abbvie,curis
['ibru', 'lymphoma', 'emavusertib', '$cris']
$cris encouraging lymphoma data at asco today - combination of emavusertib plus ibrutinib show tumor reduction in 8 of 9 evaluable patients, including 2 complete responses and 2 partial responses market may not like 2 dlts at 300mg, time will tell 
Physician & biotech investor